Difference between revisions of "Talk:Assessment of the health impacts of H1N1 vaccination/Group E"

From Testiwiki
Jump to: navigation, search
Line 9: Line 9:
  
 
{{defend|2 |The reputation of Pandemrix is globally so poor that it is impossible to use it any more.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}}
 
{{defend|2 |The reputation of Pandemrix is globally so poor that it is impossible to use it any more.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}}
−
:{{attack|9 |The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use  to recommend their use outside a pandemic situation. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST) (http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801d7bfe&jsenabled=true)}}
+
:{{attack|9 |The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use  to recommend their use outside a pandemic situation. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST),(http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801d7bfe&jsenabled=true)}}
 
:{{defend|3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST), [http://www.thl.fi/fi_FI/web/fi/uutinen?id{{eq}}22930]}}
 
:{{defend|3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST), [http://www.thl.fi/fi_FI/web/fi/uutinen?id{{eq}}22930]}}
 
::{{attack|6 |The vaccination used last year will most likely protect also against the possible swine flu epidemic of this year, although the virus has changed a bit.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:57, 1 April 2011 (EEST)[http://www.thl.fi/fi_FI/web/fi/uutinen?id{{=}}23692]}}
 
::{{attack|6 |The vaccination used last year will most likely protect also against the possible swine flu epidemic of this year, although the virus has changed a bit.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:57, 1 April 2011 (EEST)[http://www.thl.fi/fi_FI/web/fi/uutinen?id{{=}}23692]}}
 
:::{{defend|7 |Vaccination is a very good method of preventing swine flu infections.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:59, 1 April 2011 (EEST),[http://www.thl.fi/fi_FI/web/fi/uutinen?id{{=}}23692]}}
 
:::{{defend|7 |Vaccination is a very good method of preventing swine flu infections.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:59, 1 April 2011 (EEST),[http://www.thl.fi/fi_FI/web/fi/uutinen?id{{=}}23692]}}
−
:::{{defend|8 |WHO recommended that H1N1 virus strain be included in the seasonal flu vaccines for the 2009/2010 season, because H1N1 is still in circulation, but behaving like a seasonal flu virus. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST), [http://www.ema.europa.eu/ema/index.jsp?curl{{=}}pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid{{=}}WC0b01ac05801d7bfe&jsenabled{{=}}true]}}
+
:::{{defend|8 |WHO recommended that H1N1 virus strain be included in the seasonal flu vaccines for the 2009/2010 season, because H1N1 is still in circulation, but behaving like a seasonal flu virus. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST),[http://www.ema.europa.eu/ema/index.jsp?curl{{=}}pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid{{=}}WC0b01ac05801d7bfe&jsenabled{{=}}true]}}
−
:::{{defend|9 |The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use  to recommend their use outside a pandemic situation. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST) (http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801d7bfe&jsenabled=true)}}
+
:::{{defend|9 |The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use  to recommend their use outside a pandemic situation. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST),(http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801d7bfe&jsenabled=true)}}
  
 
{{attack|4 |The side effects of Pandemrix have been accentuated, although the benefits are much more significant.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:50, 1 April 2011 (EEST)[http://www.hs.fi/kotimaa/artikkeli/MTV3+Arkkiatri+moittii+sikainfluenssarokotteen+vastustajia/1135250236010]}}
 
{{attack|4 |The side effects of Pandemrix have been accentuated, although the benefits are much more significant.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:50, 1 April 2011 (EEST)[http://www.hs.fi/kotimaa/artikkeli/MTV3+Arkkiatri+moittii+sikainfluenssarokotteen+vastustajia/1135250236010]}}

Revision as of 08:18, 1 April 2011

Pandemrix should not be used because of narcolepsy risk

How to read discussions

Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.

Resolution: Resolution not yet found.

(A stable resolution, when found, should be updated to the main page.)

Argumentation:

⇤1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST)

←2 : The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST)

⇤9 : The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use to recommend their use outside a pandemic situation. {{{3}}}
←3 : In Finland, THL decided to stop the use of Pandemrix. --Jouni 23:05, 31 March 2011 (EEST), [1]
⇤6 : The vaccination used last year will most likely protect also against the possible swine flu epidemic of this year, although the virus has changed a bit. --Sallamari Tynkkynen 10:57, 1 April 2011 (EEST)[2]
←7 : Vaccination is a very good method of preventing swine flu infections. --Sallamari Tynkkynen 10:59, 1 April 2011 (EEST),[3]
←8 : WHO recommended that H1N1 virus strain be included in the seasonal flu vaccines for the 2009/2010 season, because H1N1 is still in circulation, but behaving like a seasonal flu virus. {{{3}}}
←9 : The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use to recommend their use outside a pandemic situation. {{{3}}}

⇤4 : The side effects of Pandemrix have been accentuated, although the benefits are much more significant. --Sallamari Tynkkynen 10:50, 1 April 2011 (EEST)[4]

⇤5 : Nursing staff in hospitals should be vaccinated; it is their responsibility as medical professionals. --Sallamari Tynkkynen 10:54, 1 April 2011 (EEST)http://www.hs.fi/kotimaa/artikkeli/MTV3+Arkkiatri+moittii+sikainfluenssarokotteen+vastustajia/1135250236010


Retrieved from "http://www.opasnet.org/testiwiki/index.php?title=Talk:Assessment_of_the_health_impacts_of_H1N1_vaccination/Group_E&oldid=19798"